---
title: "Sonnet BioTherapeutics Announces Board and Executive Resignations"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/268438737.md"
description: "Sonnet BioTherapeutics Holdings, Inc. announced the resignation of several board members and executives effective December 3, 2025, following a business combination. The individuals who resigned include Donald Griffith (Director, CFO), Nailesh Bhatt (Director), Albert Dyrness (Director), Lori McNeill (Director), John K. Cini (Chief Scientific Officer), Susan Dexter (Chief Technical Officer), Richard Kenney (Chief Medical Officer), and Stephen McAndrew (President and Chief Business Officer). Replacement information and board/committee role changes were not disclosed."
datetime: "2025-12-03T13:05:01.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/268438737.md)
  - [en](https://longbridge.com/en/news/268438737.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/268438737.md)
generator: "portal-rs"
---

# Sonnet BioTherapeutics Announces Board and Executive Resignations

On December 3, 2025, Sonnet BioTherapeutics Holdings, Inc. announced the resignation of several board members and executives following a business combination. The changes were effective immediately.

**Individual**

Donald Griffith

Nailesh Bhatt

Albert Dyrness

Lori McNeill

John K. Cini

Susan Dexter

Richard Kenney

Stephen McAndrew

**Role**

Director, CFO

Director

Director

Director

Chief Scientific Officer

Chief Technical Officer

Chief Medical Officer

President and Chief Business Officer

**Type of Change**

Resigned

Resigned

Resigned

Resigned

Resigned

Resigned

Resigned

Resigned

**Effective Date**

Effective Time

Effective Time

Effective Time

Effective Time

Effective Time

Effective Time

Effective Time

Effective Time

**Reason**

Business Combination

Business Combination

Business Combination

Business Combination

Business Combination

Business Combination

Business Combination

Business Combination

**Replacement Info**

Not disclosed

Not disclosed

Not disclosed

Not disclosed

Not disclosed

Not disclosed

Not disclosed

Not disclosed

**Background Details**

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

**Board/Committee Role Changes**

Not disclosed

Not disclosed

Not disclosed

Not disclosed

Not disclosed

Not disclosed

Not disclosed

Not disclosed

Original SEC Filing: Sonnet BioTherapeutics Holdings, Inc. \[ SONN \] - 8-K - Dec. 03, 2025

**Disclaimer**

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.

### Related Stocks

- [SONN.US](https://longbridge.com/en/quote/SONN.US.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**